[HTML][HTML] Deployment of convalescent plasma for the prevention and treatment of COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …
The immune response to fungal infections
During the past two decades, invasive fungal infections have emerged as a major threat to
immunocompromised hosts. Patients with neoplastic diseases are at significant risk for such …
immunocompromised hosts. Patients with neoplastic diseases are at significant risk for such …
[HTML][HTML] Advanced optoacoustic methods for multiscale imaging of in vivo dynamics
…, S Gottschalk, B Mc Larney, S Shoham… - Chemical Society …, 2017 - pubs.rsc.org
Visualization of dynamic functional and molecular events in an unperturbed in vivo environment
is essential for understanding the complex biology of living organisms and of disease …
is essential for understanding the complex biology of living organisms and of disease …
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses …
…, M Ruhnke, CS Prokop, S Shoham… - Clinical Infectious …, 2020 - academic.oup.com
… After completing the first round of working group assignments, leaders presented each
group’s initial deliberations and recommendations at the 7th Trends in Medical Mycology …
group’s initial deliberations and recommendations at the 7th Trends in Medical Mycology …
Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)
… As of the time of this publication, updates have been made to IDSA’s Guidelines on the … the
physician in the light of each patient’s individual circumstances. While the IDSA makes every …
physician in the light of each patient’s individual circumstances. While the IDSA makes every …
[HTML][HTML] Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
… We obtained consistent results with the indirect ELISAs that recognized either S or S-RBD,
in which titers of IgG, quantified as area under the curve (AUC), were greater than titers of …
in which titers of IgG, quantified as area under the curve (AUC), were greater than titers of …
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various …
…, V Thamlikitkul, DL Paterson, S Shoham… - Antimicrobial agents …, 2011 - Am Soc Microbiol
With increasing clinical emergence of multidrug-resistant Gram-negative pathogens and the
paucity of new agents to combat these infections, colistin (administered as its inactive …
paucity of new agents to combat these infections, colistin (administered as its inactive …
[HTML][HTML] Early outpatient treatment for Covid-19 with convalescent plasma
Background Polyclonal convalescent plasma may be obtained from donors who have
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3 …
…, VA Morrison, I Oren, D Selleslag, S Shoham… - The Lancet, 2016 - thelancet.com
Background Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The
SECURE trial assessed efficacy and safety of isavuconazole versus voriconazole in patients …
SECURE trial assessed efficacy and safety of isavuconazole versus voriconazole in patients …
Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects
… Considerable effort is expended to protect today’s children from lead exposure, but there
is little evidence on the harms past lead exposures continue to hold for yesterday’s children, …
is little evidence on the harms past lead exposures continue to hold for yesterday’s children, …